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Electronic health records (EHRs) from primary care providers can
be used for chronic disease surveillance; however, EHR-based
prevalence estimates may be biased toward people who seek care.
This study sought to describe the characteristics of an in-care pop-
ulation and compare them with those of a not-in-care population to
inform interpretation of EHR data.
Methods
We used data from the 2013–2014 New York City Health and Nu-
trition Examination Survey (NYC HANES), considered the gold
standard for estimating disease prevalence, and the 2013 Com-
munity Health Survey, and classified participants as in care or not
in care, on the basis of their report of seeing a health care provider
in the previous year. We used χ2 tests to compare the distribution
of demographic characteristics, health care coverage and access,
and chronic conditions between the 2 populations.
Results
According to the Community Health Survey, approximately 4.1
million (71.7%) adults aged 20 or older had seen a health care pro-
vider in the previous year; according to NYC HANES, approxim-
ately 4.7 million (75.1%) had. In both surveys, the in-care popula-
tion was more likely to be older, female, non-Hispanic, and in-
sured compared with the not-in-care population. The in-care popu-
lation from the NYC HANES also had a higher prevalence of dia-
betes (16.7% vs 6.9%; P < .001), hypercholesterolemia (35.7% vs
22.3%; P < .001), and hypertension (35.5% vs 26.4%; P < .001)
than the not-in-care population.
Conclusion
Systematic differences between in-care and not-in-care popula-
tions warrant caution in using primary care data to generalize to
the population at large. Future efforts to use primary care data for
chronic disease surveillance need to consider the intended pur-
pose of data collected in these systems as well as the characterist-
ics of the population using primary care.
Introduction
Widespread  adoption  of  electronic  health  records  (EHRs)  in
primary  care  practices  has  begun to  transform the  practice  of
medicine, with implications for patients and clinicians about the
quality, continuity, and efficiency of care. Aside from their clinic-
al utility, the richness of data in EHRs offers an opportunity to ad-
vance chronic disease surveillance through aggregating data (1). A
major advantage of EHRs for this use over other data sources is
that they can provide real-time data and clinically measured out-
comes,  which can complement  data  collected from traditional
chronic disease surveillance methods, such as registries, surveys,
and hospital discharge and medical claims databases (1). In the
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United States, national EHR incentive programs have catalyzed
the transition from paper to electronic records and have led to a
substantial volume of clinical data for public health research (2,3).
By 2014, 83% of office-based primary care practices in the United
States had adopted an EHR (4).
Although the uptake of EHRs in primary care practices presents a
unique opportunity to leverage EHR data for chronic disease sur-
veillance, the generalizability of these data for estimation of dis-
ease prevalence is of concern because some groups may be more
likely or less likely than other groups to seek primary care. Pre-
dictors of primary care use tend to be female sex, higher educa-
tional attainment, older age, lower self-rated health status, increas-
ing number of health problems, urban residence, US birth, and
longer length of residence in new country if foreign born (5–9).
Populations that may be underrepresented in EHR data might in-
clude healthy people who do not perceive a need for preventive
care or people who are unable to access care (eg, the uninsured,
undocumented immigrants) (10). The nonrandom missing data
from the not-in-care population may bias estimates of disease pre-
valence and risk factors (11). Some EHR-based surveillance stud-
ies avoid this bias by generalizing their EHR-based surveillance
data to the population in care (12,13), but others do not (14–19).
The objective of this study was to quantify hypothetical differ-
ences  in  the  demographics  and prevalence  of  risk  factors  and
chronic diseases between in-care and not-in-care populations by
using data from 2 population-based surveys of New York City res-
idents. This study will help jurisdictions, including our own, de-
termine whether to generalize their EHR-based prevalence estim-
ates to the general public, which includes both in-care and not-in-
care populations, or to generalize to the in-care population only.
Methods
Sample
We used data from the 2013 New York City Community Health
Survey (CHS) and the 2013–2014 New York City Health and Nu-
trition Examination Survey (NYC HANES). The CHS is an annu-
al telephone survey conducted by the New York City Department
of Health and Mental Hygiene (DOHMH), modeled after the Be-
havioral Risk Factor Surveillance System, and targeted to nonin-
stitutionalized adults (aged ≥18 y) with a cellular telephone or
landline living in New York City (20). NYC HANES is a com-
munity-based  examination  survey  modeled  after  the  National
Health  and  Nutrition  Examination  Survey,  first  conducted  by
DOHMH in 2004 and conducted again in 2013–2014 by the City
University of New York School of Public Health and DOHMH
jointly (21). Participants in NYC HANES were randomly selected
noninstitutionalized adults (aged ≥20 y). For the CHS, data were
restricted to participants aged 20 years or older with complete data
on sex, age group, and neighborhood poverty; 576 respondents
(6.5%) were excluded from the original sample because of these
restrictions, and the resulting sample size was 8,131. No data re-
strictions were necessary for NYC HANES (n = 1,524).
Measures
The in-care population was defined as people who saw a health
care provider in the previous year. In the CHS, in-care was defined
as an affirmative response to the following 2 questions: “Do you
have one person or more than one person you think of as your per-
sonal doctor or health care provider?” and “Have you seen your
personal doctor or health care provider in the last 12 months?” In
NYC HANES, in-care was defined as a response of one or more to
the question “During the past 12 months, how many times have
you seen a doctor or other health care professional?” and an af-
firmative response to the question “Were any of these visits in the
past 12 months at a doctor’s office or clinic for a checkup, advice
about a health problem, or basic care?” Our sensitivity analysis in-
cluded a variable to capture data on NYC HANES participants
who had seen a health care provider from 1 to 3 years previously,
defined as a response of “more than 1 year, but not more than 3
years ago” to the question “About how long has it been since you
last saw or talked to a doctor or other health care professional
about your health?”
Independent variables of interest were demographics, health care
coverage and access, health indicators, and chronic conditions.
Demographic  variables  were  age,  sex,  race/ethnicity,  marital
status,  neighborhood  poverty,  employment  status,  education,
whether  born  in  the  United  States  (50  states  and  District  of
Columbia), years in the United States (if foreign born), and inter-
view language. Neighborhood poverty was calculated as the per-
centage of population in the participant’s zip code living below
100% of the federal poverty level per the American Community
Survey (ACS) 2008–2012 and was categorized as follows: less
than 10% (low level of neighborhood poverty), 10% to 19%, 20%
to  29%,  and  30% to  100% (very  high  level  of  neighborhood
poverty). Variables for health care coverage and access were hav-
ing  any health  insurance,  having  Medicaid  coverage  (vs  non-
Medicaid coverage), and not obtaining needed medical care in the
previous 12 months. Health indicators included self-rated health
status, body mass index (BMI), smoking status, receiving an influ-
enza vaccine in the previous 12 months,  and receiving mental
health treatment (medication or counseling) in the previous 12
months. BMI was based on self-reported height and weight in the
CHS, and height and weight measurements were taken at the NYC
HANES interview. We categorized BMI (kg/m2) as underweight
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(<18.5),  normal  (18.5–24.9),  overweight  (25.0–29.9),  obese
(30.0–39.9), or extremely obese (≥40.0). A current smoker was
defined as having smoked 100 or more cigarettes in his or her life-
time and a response of “every day” or “some days” to a question
about current  smoking frequency.  Chronic condition variables
were based on history, ie, whether a participant had ever been told
he or she had depression, diabetes, hypertension, or hypercholes-
terolemia by a health care provider.  For hypercholesterolemia,
data were restricted to women aged 45 or older and men aged 35
or older to mirror the age- and sex-targeted recommendations for
routine hypercholesterolemia testing by the US Preventive Ser-
vices Task Force. Nonspecific psychological distress was defined
as a Kessler 6 (K6) score of 7 to 24 (22). In NYC HANES, we
considered additional prevalence variables (ie, “gold standard”
definitions) for diabetes (hemoglobin A1c ≥6.5, or ever told dia-
betes  and currently  taking diabetes  medication),  hypertension
(blood pressure ≥140/90 mm Hg, or ever told hypertension and
currently taking hypertension medication), and hypercholester-
olemia (total cholesterol ≥240 mg/dL, or ever told hypercholester-
olemia and currently taking cholesterol medication) because bio-
markers and information on medications were available.
Statistical analysis
We conducted bivariate analyses using Rao–Scott χ2 tests to com-
pare indicators in the CHS and NYC HANES by in-care status.
We also conducted 2 sensitivity analyses. The first sensitivity ana-
lysis compared NYC HANES participants classified as in-care (ie,
seen a health care provider in the previous year) with participants
who had last seen a health care provider from 1 to 3 years previ-
ously, to determine if we could generalize the in-care population
to people with more remote health care contact. Having health in-
surance is a major determinant of seeking care, and with the Af-
fordable Care Act (ACA), the number of Americans with health
insurance increased (23). To determine how maximal uptake of
health insurance under the ACA and subsequent care might affect
the  characteristics  of  the  in-care  population,  we  conducted  a
second sensitivity analysis. This analysis used NYC HANES data
and χ2 tests to compare the demographics and health indicators of
the in-care population and the uninsured not-in-care population.
We also computed prevalence differences for health indicators
between the in-care population and the uninsured not-in-care pop-
ulation combined with the in-care population.
All analyses were performed in SAS-callable SUDAAN (SAS ver-
sion 9.2, SAS Institute; SUDAAN version 11.0.1, RTI Internation-
al) to account for the complex sampling design. Estimates were
weighted to the New York City population based on the ACS
(2012 for CHS and 2013 for NYC HANES) and age-adjusted to
the US 2000 standard population. Significance level was set at a 2-
sided α of .05.
Results
CHS
According to the CHS, 71.7% (4,137,212) of adult New York City
residents  saw a  health  care  provider  in  the  previous  year.  We
found significant differences in all demographic characteristics, in-
surance coverage,  and health care access variables,  except  for
Medicaid coverage, between the in-care and not-in-care popula-
tions (Table 1). In-care participants were more likely to be older
(30.2% vs 10.6% for age ≥60 y), female (59.4% vs 42.0%), white
non-Hispanic (39.5% vs 31.0%), married (44.3% vs 40.8%), born
in the  United States  (51.7% vs 37.9%),  residing longer  in  the
United States if foreign born (76.8% vs 69.5% for ≥10 y), and
having an English interview (80.6% vs 65.6%) than not-in-care
participants. They were also more likely to reside in neighbor-
hoods with the lowest levels of poverty (23.0% vs 17.2%), more
likely  to  be  unemployed  or  not  in  the  labor  force  (41.8%  vs
35.8%), a college graduate (36.4% vs 28.1%), and insured (90.9%
vs 52.5%), and less likely to defer needed medical care (8.9% vs
17.0%) than not-in-care participants.
We also found significant differences in the health indicators and
chronic conditions of the in-care and not-in-care populations (Ta-
ble 2). The in-care population was more likely to have excellent
(19.2% vs 17.8%) or very good (26.9% vs 22.9%) self-rated health
and to be obese (20.6% vs 18.3%) or extremely obese (3.5% vs
2.9%). They were also less likely to be current smokers (14.9% vs
21.2%) and more likely to have received an influenza vaccine
(47.3% vs 23.1%) and mental health treatment (14.2% vs 8.0%) in
the previous 12 months. A significantly larger proportion of in-
care participants had a history of diabetes (12.5% vs 5.4%), hyper-
tension  (31.6%  vs  21.8%),  hypercholesterolemia  (39.6%  vs
23.8%), and depression (16.4% vs 13.4%). In-care participants
were less likely to have mild, moderate, or severe nonspecific psy-
chological distress (K6 score 7–24; 20.3% vs 25.6%).
NYC HANES
According to the 2013–2014 NYC HANES, 75.1% (4,701,244) of
adult New York City residents saw a health care provider in the
previous year. We found significant differences in age, sex, race/
ethnicity,  marital  status,  employment  status,  health  insurance
status, and Medicaid coverage between the in-care and not-in-care
populations (Table 1). Similar to the CHS in-care population, the
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NYC HANES in-care  population  was  more  likely  to  be  older
(27.1% vs 11.2% for age ≥60 y), female (57.2% vs 40.7%), mar-
ried  (44.1% vs  40.8%),  unemployed  or  not  in  the  labor  force
(41.0% vs 35.6%), and insured (89.2% vs 66.8%), but in contrast
to the CHS, more likely to have Medicaid (28.0% vs 17.8%) than
the not-in-care population.
We found significant differences between the 2 populations in
health indicators (Table 2). The in-care population was more likely
to have received an influenza vaccine (47.6% vs 23.3%) and men-
tal health treatment (19.2% vs 11.4%) in the previous 12 months,
and to have a history of diabetes (12.6% vs 4.8%), hypertension
(32.5% vs 16.2%), or hypercholesterolemia (43.1%  vs 20.7%).
The populations did not significantly differ in self-rated health
status, BMI, smoking status, depression, or nonspecific psycholo-
gical distress; however, the distribution of these variables in NYC
HANES was similar to their distribution in CHS. Additionally, the
in-care population had a higher prevalence of diabetes (16.7% vs
6.9%), hypertension (35.5% vs 26.4%), and hypercholesterolemia
(35.7% vs 22.3%).
In a comparison of NYC HANES participants who were in care
from 1 to 3 years previously with participants in care within the
previous year, we found significant differences in demographics
(Table 1), health indicators, and chronic conditions (Table 2). The
population in care from 1 to 3 years previously was more likely to
be younger, male, non-Hispanic, unmarried, residing in neighbor-
hoods with lower levels of poverty, employed, college graduates,
born in the United States, and uninsured. Both populations signi-
ficantly differed in health indicators and chronic conditions, and
the variables for the population in care from 1 to 3 years previ-
ously were generally distributed similarly to those of the popula-
tion not in care within the previous year.
In NYC HANES, 9.2% of the population reported being unin-
sured and not seeing any health care provider in the previous year.
The demographic characteristics and health status of these people
were significantly different from that of the in-care population.
Compared with the in-care population, the uninsured not-in-care
population was mostly younger than 60 years, male, white non-
Hispanic, and living in poorer neighborhoods; had a lower preval-
ence of obesity, hypertension, hypercholesterolemia, and diabetes;
and was less likely to have received an influenza vaccination in
the previous 12 months. In a comparison of the in-care population
and the uninsured not-in-care population combined with the in-
care population, the prevalence estimates for most health indicat-
ors differed by no more than 1.0 percentage point, with the excep-
tion of influenza vaccination (−3.3 percentage points) and hyper-
cholesterolemia (−9.4 percentage points) (Table 3).
Discussion
We identified substantial differences between the in-care popula-
tion and not-in-care population of New York City. In both sur-
veys, the in-care population was disproportionately older, female,
non-Hispanic, married, out of the labor force, more educated, in-
sured, and not living in poor neighborhoods. The in-care popula-
tion also had a higher prevalence of chronic diseases and obesity
but was less likely to smoke than the not-in-care population.
These findings support our hypothesis that the in-care and not-in-
care populations in New York City have systematic demographic
differences, and the in-care population is sicker. Our findings on
differences in age, sex, marital status, and smoking status are con-
sistent with studies conducted outside of New York City (7,8,24).
Although some EHR-based surveillance studies have not general-
ized their data to an in-care population (14–19), our results sug-
gest that at least in New York City and perhaps in other jurisdic-
tions, the in-care population is the most appropriate population for
generalizing EHR estimates because of the differences between
the in-care and not-in-care populations.
In a comparison of findings from the CHS and NYC HANES,
some variables were significantly different between populations in
one survey but not in the other; however, the directionality and
magnitude were similar for most of these variables. Some of the
observed differences were probably attributable to differences in
sample size between the 2 surveys (n = 1,524 in NYC HANES vs
n  =  8,131  in  CHS),  but  there  may  also  be  real  differences  in
sample  characteristics  attributable  to  differences  in  sampling
frames (random-digit–dialed vs address-based), incentives and
barriers to participation (financial compensation and specimen col-
lection  in  NYC  HANES),  interview  mode  (telephone  vs  in-
person), or the wording of the questions used to classify the in-
care population.
Our first sensitivity analysis revealed differences between people
who saw a health care provider within the previous year and those
who had their last health care contact from 1 to 3 years previously.
The latter were generally more similar to the not-in-care popula-
tion than they were to the population in care within the previous
year, with the exception of more likely being non-Hispanic and
born in the United States. This difference is important to consider
not only for defining the optimal population for generalizing EHR
estimates but also for defining patient inclusion criteria for the
EHR cohort. These findings support the concept that the length of
time since the most recent visit of patients sampled should paral-
lel the definition of the population to which the prevalence estim-
ates are generalized.
PREVENTING CHRONIC DISEASE VOLUME 13, E56
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY         APRIL 2016
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
4       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2016/15_0500.htm
Our second sensitivity analysis assessed how maximal insurance
uptake and health care utilization under the ACA might change the
in-care population in New York City. A lower level of chronic dis-
ease was observed in the uninsured not-in-care population, and if
this small group of people were to become insured and seek care,
we would expect a minimal decline in the prevalence estimates of
the in-care population of New York City. However, the results
should be interpreted with caution because many possible reasons
exist for why the eligible uninsured may not seek insurance under
the ACA or why people do not seek care even if insured. Further-
more,  these  findings  may  vary  by  jurisdiction,  depending  on
whether there is Medicaid expansion or not.
A major strength of this study was our use of data from 2 surveys
that represented New York City’s diverse adult population. Many
of the same questions were asked in both surveys, allowing us to
see how different survey methodologies may have influenced our
results. Furthermore, because self-reported data are subject to bias
(eg,  recall,  social  desirability),  the use of  biomarkers  in  NYC
HANES allowed us to objectively characterize BMI and chronic
health conditions of the in-care and not-in-care populations, in-
creasing confidence in our findings. Although the focus of our
study was to inform the generalizability of EHR-based prevalence
estimates, our data also offer important insights into urban health
status and unmet need for primary care among people with chron-
ic conditions. Nevertheless, our study has some limitations. The
in-care populations examined in this study might have included
people seeking primary care from nontypical primary care set-
tings  (ie,  specialists),  and our  findings may be specific  to  the
United States (or New York City) only.
The differences observed between the in-care and not-in-care adult
populations of New York City in this study confirmed our prelim-
inary decision to limit generalization of prevalence estimates gen-
erated by the NYC Macroscope to the in-care population of New
York City. (The NYC Macroscope is a surveillance system that
uses EHRs to track chronic conditions managed by primary care
p r a c t i c e s  [ w w w . n y c . g o v / h t m l / d o h / h t m l / d a t a /
nycmacroscope.shtml]). Consequently, we are using data on age,
sex, and neighborhood poverty distribution from the CHS in-care
population to weight NYC Macroscope estimates. We validated
2013 NYC Macroscope prevalence estimates of smoking, obesity,
depression, and influenza vaccination as well as data on the pre-
valence, treatment, and control of diabetes, hypertension, and hy-
percholesterolemia against in-care population estimates from the
CHS and NYC HANES (25).
This study found significant differences between the in-care and
not-in-care populations in New York City. Surveillance systems
that use EHRs from primary care practices for monitoring chronic
diseases should consider the intended purpose of the data collec-
ted and the systematic differences between in-care and not-in-care
populations in the generalization of results.
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Tables
Table 1. Demographics, Health Care Coverage, and Access to Care Among New York City Adults in Care and Not in Care,
2013–2014a
Characteristic
2013 Community Health Survey











Year P b, c
In Care From 1 to
3 Years
Previouslyd P b, e
Sample size, nf 6,166 1,921  — 1,135 386 — 200  —
Weighted sample size,
n


















36.6 (33.4–40.0) 30.2 (24.9–36.1) 25.2 (18.5–33.3)
≥60 30.2
(28.7–31.7)



































25.8 (21.7–30.4) 30.5 (23.5–38.5) 22.2 (16.0–29.9)
Asian non-Hispanich 12.4 12.3 13.8 (10.6–17.9) 13.1 (9.3–18.2) 15.1 (9.9–22.5)
Abbreviations: —, not applicable; GED, general educational development.
a All values are percentage (95% confidence interval) unless otherwise indicated. Column percentages may not add up to 100% because of rounding.
b All P values determined by Rao–Scott χ2 test.
c NYC HANES not in care within previous year vs NYC HANES in care within previous year.
d Defined as a response of “more than 1 year, but not more than 3 years ago” to the question “About how long has it been since you last saw or talked to a doctor
or other health care professional about your health?”
e NYC HANES in care from 1 to 3 years previously vs NYC HANES in care within previous year.
f Sample sizes for the Community Health Survey in this row do not add to 8,131 (total sample size) because 44 participants did not respond (refused or responded
with “don’t know”) to the in-care questions and were dropped from the analyses. For the NYC HANES, 3 participants did not respond, so sample sizes in this row do
not add to 1,524 (total sample size).
g Proportion relative to the population in care within 3 years.
h Non-Hispanic Pacific Islanders are categorized as “Asian non-Hispanic” in the Community Health Survey, and “other non-Hispanic” in NYC HANES.
i Estimate should be interpreted with caution. Estimate’s relative standard error (a measure of estimate precision) is greater than 30%, the 95% confidence inter-
val half-width is greater than 10, or the sample size is too small, making the estimate potentially unreliable.
j Percentage of population in the participant’s zip code living below 100% of the federal poverty level per the American Community Survey 2008–2012.
(continued on next page)
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(continued)
Table 1. Demographics, Health Care Coverage, and Access to Care Among New York City Adults in Care and Not in Care,
2013–2014a
Characteristic
2013 Community Health Survey











Year P b, c
In Care From 1 to
3 Years
Previouslyd P b, e
(11.2–13.6) (10.4–14.5)















14.0 (12.0–16.3) 11.2 (7.7–16.2) 14.1 (8.1–23.3)





28.7(25.7–32.0) 35.0 (29.5–40.9) 38.1 (30.3–46.6)




















23.1 (16.5–31.4) 23.2 (15.2–33.7) 19.5 (11.9–30.2)





















41.0 (37.8–44.4) 35.6 (29.7–41.9) 29.3 (22.1–37.6)
Abbreviations: —, not applicable; GED, general educational development.
a All values are percentage (95% confidence interval) unless otherwise indicated. Column percentages may not add up to 100% because of rounding.
b All P values determined by Rao–Scott χ2 test.
c NYC HANES not in care within previous year vs NYC HANES in care within previous year.
d Defined as a response of “more than 1 year, but not more than 3 years ago” to the question “About how long has it been since you last saw or talked to a doctor
or other health care professional about your health?”
e NYC HANES in care from 1 to 3 years previously vs NYC HANES in care within previous year.
f Sample sizes for the Community Health Survey in this row do not add to 8,131 (total sample size) because 44 participants did not respond (refused or responded
with “don’t know”) to the in-care questions and were dropped from the analyses. For the NYC HANES, 3 participants did not respond, so sample sizes in this row do
not add to 1,524 (total sample size).
g Proportion relative to the population in care within 3 years.
h Non-Hispanic Pacific Islanders are categorized as “Asian non-Hispanic” in the Community Health Survey, and “other non-Hispanic” in NYC HANES.
i Estimate should be interpreted with caution. Estimate’s relative standard error (a measure of estimate precision) is greater than 30%, the 95% confidence inter-
val half-width is greater than 10, or the sample size is too small, making the estimate potentially unreliable.
j Percentage of population in the participant’s zip code living below 100% of the federal poverty level per the American Community Survey 2008–2012.
(continued on next page)
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(continued)
Table 1. Demographics, Health Care Coverage, and Access to Care Among New York City Adults in Care and Not in Care,
2013–2014a
Characteristic
2013 Community Health Survey











Year P b, c
In Care From 1 to
3 Years


































<.001 49.5 (45.0–54.0) 48.6 (41.9–55.3) .50 59.8 (50.7–68.2) .002
































9.6 (7.2–12.7) 13.8 (8.4–22.0) 4.1i (2.0–8.3)
Russian 2.8 (2.3–3.4) 2.9 (1.9–4.4) 3.6i (1.9–6.8) 3.7i (1.4–9.5) 5.0i (1.9–12.5)
Chinese 5.3 (4.6–6.2) 5.8 (4.5–7.5) 1.8i (0.9–3.5) 1.1i (0.3–4.5) 1.6i (0.2–10.3)
Other — — 0.3i (0.1–0.9) 1.0i (0.2–3.8) 1.0i (0.1–7.1)
Abbreviations: —, not applicable; GED, general educational development.
a All values are percentage (95% confidence interval) unless otherwise indicated. Column percentages may not add up to 100% because of rounding.
b All P values determined by Rao–Scott χ2 test.
c NYC HANES not in care within previous year vs NYC HANES in care within previous year.
d Defined as a response of “more than 1 year, but not more than 3 years ago” to the question “About how long has it been since you last saw or talked to a doctor
or other health care professional about your health?”
e NYC HANES in care from 1 to 3 years previously vs NYC HANES in care within previous year.
f Sample sizes for the Community Health Survey in this row do not add to 8,131 (total sample size) because 44 participants did not respond (refused or responded
with “don’t know”) to the in-care questions and were dropped from the analyses. For the NYC HANES, 3 participants did not respond, so sample sizes in this row do
not add to 1,524 (total sample size).
g Proportion relative to the population in care within 3 years.
h Non-Hispanic Pacific Islanders are categorized as “Asian non-Hispanic” in the Community Health Survey, and “other non-Hispanic” in NYC HANES.
i Estimate should be interpreted with caution. Estimate’s relative standard error (a measure of estimate precision) is greater than 30%, the 95% confidence inter-
val half-width is greater than 10, or the sample size is too small, making the estimate potentially unreliable.
j Percentage of population in the participant’s zip code living below 100% of the federal poverty level per the American Community Survey 2008–2012.
(continued on next page)
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(continued)
Table 1. Demographics, Health Care Coverage, and Access to Care Among New York City Adults in Care and Not in Care,
2013–2014a
Characteristic
2013 Community Health Survey











Year P b, c
In Care From 1 to
3 Years
Previouslyd P b, e
No health insurance 9.1 (7.9–10.4) 47.5
(44.1–50.8)















72.0 (67.4–76.3) 82.2 (76.4–86.9) 81.9 (72.8–88.5)





<.001 8.7 (7.2–10.6) 10.6 (7.7–14.4) .22 10.4 (6.8–15.5) .32
Abbreviations: —, not applicable; GED, general educational development.
a All values are percentage (95% confidence interval) unless otherwise indicated. Column percentages may not add up to 100% because of rounding.
b All P values determined by Rao–Scott χ2 test.
c NYC HANES not in care within previous year vs NYC HANES in care within previous year.
d Defined as a response of “more than 1 year, but not more than 3 years ago” to the question “About how long has it been since you last saw or talked to a doctor
or other health care professional about your health?”
e NYC HANES in care from 1 to 3 years previously vs NYC HANES in care within previous year.
f Sample sizes for the Community Health Survey in this row do not add to 8,131 (total sample size) because 44 participants did not respond (refused or responded
with “don’t know”) to the in-care questions and were dropped from the analyses. For the NYC HANES, 3 participants did not respond, so sample sizes in this row do
not add to 1,524 (total sample size).
g Proportion relative to the population in care within 3 years.
h Non-Hispanic Pacific Islanders are categorized as “Asian non-Hispanic” in the Community Health Survey, and “other non-Hispanic” in NYC HANES.
i Estimate should be interpreted with caution. Estimate’s relative standard error (a measure of estimate precision) is greater than 30%, the 95% confidence inter-
val half-width is greater than 10, or the sample size is too small, making the estimate potentially unreliable.
j Percentage of population in the participant’s zip code living below 100% of the federal poverty level per the American Community Survey 2008–2012.
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Table 2. Health Indicators and Chronic Conditions Among New York City Adults in Care and Not in Care, 2013–2014a
Indicator or Condition
2013 Community Health Survey













Previous Year P b, c
In Care From 1
to 3 Years
Previouslyd P b, e
Sample size, nf 6,166 1,921  — 1,135 386  — 200  —



















































Underweight 2.5 (1.9–3.2) 3.8 (2.6–5.5)
.007











































Abbreviations: —, not applicable; HbA1c, glycated hemoglobin.
a All values are percentage (95% confidence interval) unless otherwise indicated. Column percentages may not add up to 100% because of rounding.
b All P values determined by Rao–Scott χ2 test.
c NYC HANES not in care within previous year vs NYC HANES in care within previous year.
d Defined as a response of “more than 1 year, but not more than 3 years ago” to the question “About how long has it been since you last saw or talked to a doctor
or other health care professional about your health?”
e NYC HANES in care from 1 to 3 years ago vs NYC HANES in care within previous year.
f Sample sizes for the Community Health Survey in this row do not add to 8,131 (total sample size) because 44 participants did not respond (refused or responded
with “don’t know”) to the in-care questions and were dropped from the analyses. For the NYC HANES, 3 participants did not respond, so sample sizes in this row do
not add to 1,524 (total sample size).
g Proportion relative to the population in care within 3 years.
h For CHS, based on self-reported height and weight; for NYC HANES, based on height and weight measurements taken at interview. Categorized (kg/m2) as under-
weight (<18.5), normal (18.5–24.9), overweight (25.0–29.9), obese (30.0–39.9), or extremely obese (≥40.0).
i Estimate should be interpreted with caution. Estimate’s relative standard error (a measure of estimate precision) is greater than 30%, the 95% confidence inter-
val half-width is greater than 10, or the sample size is too small, making the estimate potentially unreliable.
j Current smoker defined as having smoked ≥100 cigarettes in his or her lifetime and a response of “every day” or “some days” to a question about the current
smoking frequency.
k Data restricted to women aged ≥45 years and men aged ≥35 years.
(continued on next page)
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(continued)
Table 2. Health Indicators and Chronic Conditions Among New York City Adults in Care and Not in Care, 2013–2014a
Indicator or Condition
2013 Community Health Survey













Previous Year P b, c
In Care From 1
to 3 Years





























<.001 23.0 (16.3–31.3) <.001
Mental health








.21 10.8 (6.5–17.3) .12
Nonspecific psychological distress (score on Kessler 6 scale [22])




















  Severe (13–24) 5.2 (4.5–6.1) 6.6 (4.8–9.0) 4.8 (3.5–6.5) 5.8 (3.3–10.0) 5.8i (3.0–11.2)
Received mental health








<.001 9.3 (5.3–15.8) <.001
Diabetes
Ever told had diabetes 12.5
(11.5–13.5)
5.4 (4.0–7.3) <.001 12.6
(10.6–14.8)
4.8i (2.5–9.0) <.001 2.5i (0.7–8.8) <.001
HbA1c ≥6.5 or ever told
diabetes and takes
medication
— — — 16.7
(14.3–19.3)
6.9 (4.1–11.3) <.001 4.8i (2.0–10.9) <.001
Hypertension
Abbreviations: —, not applicable; HbA1c, glycated hemoglobin.
a All values are percentage (95% confidence interval) unless otherwise indicated. Column percentages may not add up to 100% because of rounding.
b All P values determined by Rao–Scott χ2 test.
c NYC HANES not in care within previous year vs NYC HANES in care within previous year.
d Defined as a response of “more than 1 year, but not more than 3 years ago” to the question “About how long has it been since you last saw or talked to a doctor
or other health care professional about your health?”
e NYC HANES in care from 1 to 3 years ago vs NYC HANES in care within previous year.
f Sample sizes for the Community Health Survey in this row do not add to 8,131 (total sample size) because 44 participants did not respond (refused or responded
with “don’t know”) to the in-care questions and were dropped from the analyses. For the NYC HANES, 3 participants did not respond, so sample sizes in this row do
not add to 1,524 (total sample size).
g Proportion relative to the population in care within 3 years.
h For CHS, based on self-reported height and weight; for NYC HANES, based on height and weight measurements taken at interview. Categorized (kg/m2) as under-
weight (<18.5), normal (18.5–24.9), overweight (25.0–29.9), obese (30.0–39.9), or extremely obese (≥40.0).
i Estimate should be interpreted with caution. Estimate’s relative standard error (a measure of estimate precision) is greater than 30%, the 95% confidence inter-
val half-width is greater than 10, or the sample size is too small, making the estimate potentially unreliable.
j Current smoker defined as having smoked ≥100 cigarettes in his or her lifetime and a response of “every day” or “some days” to a question about the current
smoking frequency.
k Data restricted to women aged ≥45 years and men aged ≥35 years.
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(continued)
Table 2. Health Indicators and Chronic Conditions Among New York City Adults in Care and Not in Care, 2013–2014a
Indicator or Condition
2013 Community Health Survey













Previous Year P b, c
In Care From 1
to 3 Years
Previouslyd P b, e








<.001 15.2 (9.7–23.1) <.001
Blood pressure ≥140/90 mm
Hg or ever told hypertension
and takes medication
















<.001 21.3 (13.1–32.9) <.001











Abbreviations: —, not applicable; HbA1c, glycated hemoglobin.
a All values are percentage (95% confidence interval) unless otherwise indicated. Column percentages may not add up to 100% because of rounding.
b All P values determined by Rao–Scott χ2 test.
c NYC HANES not in care within previous year vs NYC HANES in care within previous year.
d Defined as a response of “more than 1 year, but not more than 3 years ago” to the question “About how long has it been since you last saw or talked to a doctor
or other health care professional about your health?”
e NYC HANES in care from 1 to 3 years ago vs NYC HANES in care within previous year.
f Sample sizes for the Community Health Survey in this row do not add to 8,131 (total sample size) because 44 participants did not respond (refused or responded
with “don’t know”) to the in-care questions and were dropped from the analyses. For the NYC HANES, 3 participants did not respond, so sample sizes in this row do
not add to 1,524 (total sample size).
g Proportion relative to the population in care within 3 years.
h For CHS, based on self-reported height and weight; for NYC HANES, based on height and weight measurements taken at interview. Categorized (kg/m2) as under-
weight (<18.5), normal (18.5–24.9), overweight (25.0–29.9), obese (30.0–39.9), or extremely obese (≥40.0).
i Estimate should be interpreted with caution. Estimate’s relative standard error (a measure of estimate precision) is greater than 30%, the 95% confidence inter-
val half-width is greater than 10, or the sample size is too small, making the estimate potentially unreliable.
j Current smoker defined as having smoked ≥100 cigarettes in his or her lifetime and a response of “every day” or “some days” to a question about the current
smoking frequency.
k Data restricted to women aged ≥45 years and men aged ≥35 years.
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Table 3. Health Indicators and Chronic Conditions Among the In-Care Population Combined With the Uninsured Not-in-Care Popula-
tion in New York City, 2013–2014a
Indicator or Condition Prevalence Estimate, %b (95% CI)
Difference in Prevalence Between Existing
In-Care Population and the In-Care
Population Combined With the Uninsured
Not-in-Care Population, Percentage Point
Body mass indexc
Underweight 1.8 (1.2–2.8) −0.1
Normal 32.4 (29.6–35.4) 0.3
Overweight 35.1 (32.7–37.6) 0.5
Obese 26.1 (23.4–28.9) −0.1
Extremely obese 4.6 (3.4–6.1) −0.5
Smoking statusd
Current 18.5 (16.0–21.3) 0.8
Former 21.7 (19.3–24.4) 0.2
Never 59.7 (56.4–63.0) −0.9
Received influenza vaccine in previous 12 months 44.3 (40.9–47.7) −3.3
Nonspecific psychological distress (score on Kessler 6 scale [22])
No or low  (0–6) 77.8 (74.8–80.6) −0.2
Mild or moderate (7–12) 17.6 (15.3–20.1) 0.3
Severe (13–24) 4.6 (3.4–6.2) −0.2
Blood pressure ≥140/90 mm Hg or ever told
hypertension and takes medication
34.6 (31.6–37.6) −1.0
Total cholesterol ≥240 mg/dL or ever told
hypercholesterolemia and takes medicatione
26.3 (23.4–29.4) −9.4
HbA1c ≥6.5 or ever told diabetes and takes
medication
15.7 (13.4–18.4) −1.0
Abbreviations: HbA1c, glycated hemoglobin; CI, confidence interval.
a Data source: 2013–2014 New York City Health and Nutrition Examination Survey (NYC HANES) (21).
b Column percentages may not add up to 100% because of rounding.
c Based on height and weight measurements taken at the NYC HANES interview. Categorized (kg/m2) as underweight (<18.5), normal (18.5–24.9), overweight
(25.0–29.9), obese (30.0–39.9), or extremely obese (≥40.0).
d Current smoker defined as having smoked ≥100 cigarettes in his or her lifetime and a response of “every day” or “some days” to a question about the current
smoking frequency.
e Data restricted to women aged ≥45 years and men aged ≥35 years.
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